Neurofibromatosis Therapeutic Acceleration Program

Congratulations to Dr. Helena Mazuelas Gallego, Ph.D. and the Serra Lab team for winning first place in the Basic Science Poster Competition at the Global NF Children's Tumor Foundation's conference!   Dr. Serra’s lab focuses on the study of #NF1-associated tumors emerging in the peripheral nervous system (PNS). The team studies the development, composition, progression and potential therapy and management of these tumors.    Learn more: https://lnkd.in/g-BgAqWS   #NF1Therapies #Neuroscience #NFAwareness #Neurofibromatosis

This is how the needle gets moved! The #NF1 Nerve Sheath Tumor Biomarker Development Symposium brought together creative thinkers and powerful do-ers to identify the most promising liquid, tissue, imaging and digital records markers to inform therapeutics for NF1 tumors. At NTAP, we are working with leaders in the field to synthesize the data and opportunities and will announce new research opportunities soon. Learn more here: https://lnkd.in/gDAQy3uV #NF1Therapies #Neuroscience #NFAwareness #Neurofibromatosis

The Children's Tumor Foundation is hosting #Neurofibromatosis scientists and clinicians at the 2024 Global #NF Conference in Brussels from June 20 - 25. We are looking forward to a variety of presentations from NTAP’s own sponsored investigators, where data on the advancement of drug development and improved outcomes for patients will be shared. With over 20 projects connected to our efforts, NTAP investigators are leading the #NF1 field and setting the trajectory for conference discussions. Learn more about the event and our presentations here: https://lnkd.in/gnHnBf_a #NF1Therapies #Neuroscience

We are once again seeking applications from exceptional early-stage clinician scientists who want to be part of the cure for #Neurofibromatosis! NTAP and Johns Hopkins Medicine are now accepting applications for #FrancisSCollinsScholars program in Neurofibromatosis Clinical and Translational Research. Join a community of leaders in clinical translational science and change the future of #NF1 research and clinical care. Learn more and apply at: https://lnkd.in/eq3t7hxh #NF1Therapies #Neuroscience

We are proud to lead the natural history study of cNFs in #NF1. Our goals are to better understand how skin tumors in people with NF1 progress and identify populations at risk that may benefit from early interventions in order to inform clinical discussions and serve as a historic control for future clinical trials. Learn more here: https://lnkd.in/gujdAhBr Johns Hopkins Medicine

Gene therapy focused breakthroughs for #NF1 require collaboration from the best. So grateful for this community of brilliant and powerful thinkers. Onward! Gilbert Family Foundation Children's Tumor Foundation

We were happy to organize and host The Symposium on Atypical Neurofibroma State of the Science as a collaboration between the National Cancer Institute (NCI) and NTAP Research. Two people living with NF1 and 56 scientists and clinicians from 27 institutions in the USA and Europe participated in a think tank to review current data and major priorities for pre-malignant #neurofibromas. The outcomes were the first steps toward an updated diagnostic paradigm that includes histopathology, clinical features, imaging and genomics. New recommendations were also established regarding diagnosis, monitoring and management options. The goal is to never let another #MPNST / sarcoma happen. Audacious, but with this team, maybe just achievable. #NF1Therapies #NF1 #Neuroscience #NFAwareness #Neurofibromatosis

The Johns Hopkins University Dome is lit up in blue and green in recognition of #NFAwareness month and the efforts of the JHU Comprehensive #Neurofibromatosis Center to discover meaningful treatments for all forms of #NF1 and #schwannomatosis. Our team is grateful for the funding and support from the community near and far as we continue accelerating the development of effective therapeutics for plexiform and cutaneous #neurofibromas and provide the best possible care for patients. #NF1Therapies #NF1 #Neuroscience #NFAwareness #Neurofibromatosis

The Johns Hopkins University Dome is lit up in blue and green in recognition of #NFAwareness month and the efforts of the JHU Comprehensive #Neurofibromatosis Center to discover meaningful treatments for all forms of #NF1 and #schwannomatosis. Our team is grateful for the funding and support from the community near and far as we continue accelerating the development of effective therapeutics for plexiform and cutaneous #neurofibromas and provide the best possible care for patients. #NF1Therapies #NF1 #Neuroscience #NFAwareness #Neurofibromatosis

We were happy to organize and host The Symposium on Atypical Neurofibroma State of the Science as a collaboration between the National Cancer Institute (NCI) and NTAP Research. Two people living with NF1 and 56 scientists and clinicians from 27 institutions in the USA and Europe participated in a think tank to review current data and major priorities for pre-malignant #neurofibromas. The outcomes were the first steps toward an updated diagnostic paradigm that includes histopathology, clinical features, imaging and genomics. New recommendations were also established regarding diagnosis, monitoring and management options. The goal is to never let another #MPNST / sarcoma happen. Audacious, but with this team, maybe just achievable. #NF1Therapies #NF1 #Neuroscience #NFAwareness #Neurofibromatosis